Dutch pension plan-backed investment group Inkef Capital has made a €7.5m investment in brain stimulation company Sapiens as part of its Series A round.
The financing brings the total raised by Sapiens in the Series A to €24m thanks to previous investment from Wellington Partners, Edmond de Rothschild Investment Partners, LSP and the Wellcome Trust in 2011.
Sapiens is attempting to develop electric pulse-based treatments for conditions including Parkinson’s disease and other functional brain disorders.
Inkef, which stands for Investing in the Knowledge Economy of the Future, was established and funded by the Netherlands’ largest pension fund ABP.
It focuses on developing intellectual property-based new technologies across sectors including life sciences, nanotechnology and IT.
Inkef founder Frank Landsberger will join the Sapiens advisory board following the investment.
He said, “”Sapiens has the promise of bringing significant therapeutic improvement to patients suffering from Parkinson’s disease and other serious brain disorders.
“Inkef is delighted to join a first rate investment consortium aimed at bringing Sapiens’ products to the market for the benefit of these patients.”
Copyright © 2013 AltAssets